MedPath

天津生物化学制药有限公司

Ownership
-
Established
1980-09-19
Employees
-
Market Cap
-
Website
http://www.tjshenghua.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

NMPA:54

Drug Approvals

Azithromycin Maleate Injection

Product Name
马来酸阿奇霉素注射液
Approval Number
国药准字H20060810
Approval Date
Apr 13, 2021
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H12020482
Approval Date
Apr 9, 2021
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H12020487
Approval Date
Apr 9, 2021
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20063545
Approval Date
Apr 9, 2021
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20063546
Approval Date
Apr 9, 2021
NMPA

Nadroparin Calcium

Product Name
那屈肝素钙
Approval Number
国药准字H20160003
Approval Date
Dec 11, 2020
NMPA

Nadroparin Calcium Injection

Product Name
那屈肝素钙注射液
Approval Number
国药准字H20163048
Approval Date
Dec 11, 2020
NMPA

Nadroparin Calcium Injection

Product Name
那屈肝素钙注射液
Approval Number
国药准字H20163047
Approval Date
Dec 11, 2020
NMPA

Defibrase for Injectio

Product Name
注射用降纤酶
Approval Number
国药准字H19983224
Approval Date
Sep 21, 2020
NMPA

Ocular Extractives Injection

Product Name
眼氨肽注射液
Approval Number
国药准字H12021054
Approval Date
Sep 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.